BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma

Histopathology
Sylvia HoellerAlexandar Tzankov

Abstract

To clarify which immunohistochemical markers could be helpful in distinguishing between classical Hodgkin's lymphoma (cHL) and primary mediastinal B-cell lymphoma (PMBCL) to more narrowly define 'B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and cHL'. Two hundred and 83 cHLs and 51 PMBCLs were analysed on validated tissue microarray platforms with antibodies to BOB.1, CD15, CD20, CD23, CD30, CD79a, cyclin E, LMP-1, MUM1p, p63 and Oct2. The marker cut-off scores were calculated using receiver-operating characteristic curves. Markers with the highest positive predictive value for cHL were: CD15, cyclin E, LMP-1 (all 100%), MUM1p (93%) and CD30 (83%). High sensitivity was achieved only by CD30 (92%) and cyclin E (79%). Nineteen percent of PMBCLs were also positive for CD30, which led to a lower specificity of CD30 as regards cHL (81%) compared with cyclin E (100%). The antibodies with the highest positive predictive value for PMBCL were: CD23 (98%), p63 (96%), BOB.1 (94%) and CD79a (90%), with high sensitivity for BOB.1 (100%), CD79a (89%) and p63 (82%). The use of at least three of the most accurate immunohistochemical markers, cyclin E, CD79a and BOB.1, may be helpful in the di...Continue Reading

References

Mar 21, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Ana-Isabel SáezMiguel A Piris
Apr 26, 2002·British Journal of Haematology·Antonino CarboneGianluca Gaidano
Nov 14, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Christiane Copie-BergmanPhilippe Gaulard
Nov 14, 2003·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Alexandar TzankovStephan Dirnhofer
Jul 17, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Mónica García-CosíoCarmen Bellas
May 28, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Alberto ZamòFabio Menestrina
Oct 15, 2005·The American Journal of Surgical Pathology·Alexandra Traverse-GlehenElaine S Jaffe
Oct 21, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K J SavageJ M Connors
Jan 18, 2006·American Journal of Epidemiology·Neil J Perkins, Enrique F Schisterman
Apr 13, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alexandar TzankovPhilip Went
May 2, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Ryan C McCuneMohammad A Vasef
May 19, 2006·American Journal of Clinical Pathology·Eric D HsiBrad Pohlman
Nov 7, 2006·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Alexandar Tzankov, Stephan Dirnhofer
Nov 9, 2007·The New England Journal of Medicine·Volker Diehl
May 3, 2008·Leukemia & Lymphoma·José RodríguezMiguel Piris
Jan 13, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Cecile MeierAlexandar Tzankov

❮ Previous
Next ❯

Citations

Jan 16, 2013·Der Pathologe·S Hartmann, M L Hansmann
Aug 9, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Franziska C EberleElaine S Jaffe
Jan 10, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Gabriela GualcoCarlos E Bacchi
Jun 22, 2014·Current Hematologic Malignancy Reports·Anna Dabrowska-Iwanicka, Jan A Walewski
Jan 26, 2011·Journal of Cutaneous Pathology·Begoña VieitesFrancisco Carvajo
Jan 3, 2015·Archives of Pathology & Laboratory Medicine·Dennis P O'MalleyLawrence M Weiss
May 2, 2012·Advances in Hematology·Sylvia Hoeller, Christiane Copie-Bergman
Sep 10, 2014·Applied Immunohistochemistry & Molecular Morphology : AIMM·Thomas MenterAlexandar Tzankov
Jun 9, 2016·Advances in Anatomic Pathology·Penelope KorkolopoulouMaria Ioannou
Jul 22, 2016·Advances in Anatomic Pathology·Sergio Piña-Oviedo, Cesar A Moran
Oct 9, 2015·Applied Immunohistochemistry & Molecular Morphology : AIMM·Dennis P O'MalleyLawrence M Weiss
Jul 10, 2020·Journal of Clinical and Experimental Hematopathology : JCEH·Akio SakataniTadashi Yoshino
Mar 10, 2016·International Journal of Surgical Pathology·Anuj VermaShripad Banavali
Feb 12, 2019·British Journal of Haematology·Charlotte LeesJay Gunawardana
Dec 4, 2019·Applied Immunohistochemistry & Molecular Morphology : AIMM·Danielle L V MaracajaMina L Xu
Jun 3, 2021·Advances in Anatomic Pathology·Sergio Pina-Oviedo
Feb 26, 2019·Annals of Diagnostic Pathology·Dennis P O'MalleyMohamed E Salama

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.